Lonza | LONN - Gross Profit On Sales


Lonza reported CHF1.29B in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Akzo Nobel EUR 978M 42M Mar/2026
Alcon AG USD 1.69B 175M Mar/2026
Almirall EUR 429.87M 180.02M Dec/2025
AstraZeneca USD 12.86B 251M Jun/2026
BASF EUR 4.33B 181M Jun/2026
Bayer EUR 8.17B 1.24B Mar/2026
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 212M 276M Dec/2025
Demant DKK 8.82B 277M Dec/2025
Fresenius EUR 1.55B 16M Jun/2026
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Geberit CHF 524.3M 125.1M Dec/2025
Genmab DKK 1.07B 240M Jun/2026
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 6.51B 757M Jun/2026
GN Store Nord DKK 2.5B 344M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Johnson Matthey GBP 480M 33M Jun/2024
Merck EUR 3.07B 104M Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Philips EUR 2.15B 384M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Sanofi EUR 8.71B 602M Jun/2026
Sika AG CHF 3.02B 104.6M Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025
Solvay EUR 213M 53M Jun/2026
UCB EUR 3.19B 621M Dec/2025